Oric Pharmaceuticals, Inc.
ORICFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Oric Pharmaceuticals, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Feb 26, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 2026-03-31 | 298 | $3.78K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 8,984 | $114K | SEC filing |
| Boxer Capital Management, LLC | 2026-03-31 | 176,500 | $2.24M | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 77 | $976 | SEC filing |
| MPM BIOIMPACT LLC | 2026-03-31 | 1,803,945 | $22.9M | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 43,137 | $547K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 79,063 | $1M | SEC filing |
| BRAIDWELL LP | 2026-03-31 | 1,128,040 | $14.3M | SEC filing |
| Brevan Howard Capital Management LP | 2026-03-31 | 19,709 | $250K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 263,059 | $3.33M | SEC filing |
| AIHC Capital Management Ltd | 2026-03-31 | 2,459,551 | $31.2M | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 19,131 | $242K | SEC filing |
| SECTORAL ASSET MANAGEMENT INC | 2026-03-31 | 23,500 | $333K | SEC filing |
| ROYCE & ASSOCIATES LP | 2026-03-31 | 1,207,223 | $15.3M | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 23,055 | $292K | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 173 | $2.19K | SEC filing |
| EcoR1 Capital, LLC | 2026-03-31 | 6,728,116 | $85.2M | SEC filing |
| Quarry LP | 2026-03-31 | 21,840 | $277K | SEC filing |
| Invesco Ltd. | 2026-03-31 | 108,954 | $1.38M | SEC filing |
| Woodline Partners LP | 2026-03-31 | 1,247,515 | $15.8M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Oric Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2022-05-11 · Chacko Jacob: Larger than all 8 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-24 | Piscitelli Dominic · Chief Financial Officer | Common Stock | S — Open market or private sale | −52,000 | 13.51 | SEC filing |
| 2026-01-16 | Heyman Richard A. · Director | Common Stock | S — Open market or private sale | −3,200 | 12.00 | SEC filing |
| 2026-01-16 | Heyman Richard A. · Director | Common Stock | S — Open market or private sale | −3,500 | 12.00 | SEC filing |
| 2025-12-16 | Piscitelli Dominic · Chief Financial Officer | Common Stock | S — Open market or private sale | −10,720 | 9.06 | SEC filing |
| 2025-12-16 | Multani Pratik S · Chief Medical Officer | Common Stock | S — Open market or private sale | −10,720 | 9.06 | SEC filing |
| 2025-12-16 | Chacko Jacob · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −33,374 | 9.06 | SEC filing |
| 2025-10-06 | Piscitelli Dominic · Chief Financial Officer | Common Stock | S — Open market or private sale | −11,000 | 14.52 | SEC filing |
| 2025-10-06 | Chacko Jacob · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −37,461 | 12.32 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-24 | Piscitelli Dominic · Chief Financial Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −52,000 | SEC filing |
| 2026-02-24 | Piscitelli Dominic · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +52,000 | SEC filing |
| 2026-01-02 | Heyman Richard A. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-01-02 | Dier Mardi · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-01-02 | Hoerter Steven L. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
| 2026-01-02 | Multani Pratik S · Chief Medical Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +214,000 | SEC filing |
| 2026-01-02 | Chacko Jacob · PRESIDENT AND CEO | Restricted Stock Unit | A — Grant, award, or other acquisition | +112,500 | SEC filing |
| 2026-01-02 | You Angie · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +40,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-07-20 | Chacko Jacob · President and CEO | Stock Option (right to buy) | D — Disposition to the issuer | −280,000 | SEC filing |
| 2022-07-20 | Chacko Jacob · President and CEO | Stock Option (right to buy) | D — Disposition to the issuer | −300,000 | SEC filing |
| 2022-07-20 | Chacko Jacob · President and CEO | Stock Option (right to buy) | D — Disposition to the issuer | −437,500 | SEC filing |
| 2022-07-20 | Multani Pratik S · Chief Medical Officer | Stock Option (right to buy) | D — Disposition to the issuer | −90,000 | SEC filing |
| 2022-07-20 | Piscitelli Dominic · Chief Financial Officer | Stock Option (right to buy) | D — Disposition to the issuer | −86,250 | SEC filing |
| 2022-07-20 | Multani Pratik S · Chief Medical Officer | Stock Option (right to buy) | D — Disposition to the issuer | −147,500 | SEC filing |
| 2022-07-20 | Piscitelli Dominic · Chief Financial Officer | Stock Option (right to buy) | D — Disposition to the issuer | −207,500 | SEC filing |
| 2022-07-20 | Piscitelli Dominic · Chief Financial Officer | Stock Option (right to buy) | D — Disposition to the issuer | −90,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.